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Introduction
Lateral spreading tumors (LST) are considered important pre-
cursors of colorectal cancer [1]. LST were first described by
Kudo as tumors with predominant spread within the mucosa
while still relatively flat [2]. In the Paris consensus of 2002, LST
were defined as nonpolypoid lesions larger than 10mm in width
that typically extend laterally and circumferentially along the
colonic wall, rather than vertically and were classified as type
0-IIa [3]. LST are distinguished based on their granular or non-
granular, homogenous or nonhomogenous appearance [1].
These lesions have been described in several studies with a
wide range of definitions, not always concordant. Therefore, it
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ABSTRACT
Objective and study aims To evaluate the efficacy and
safety of different endoscopic resection techniques for lat-
erally spreading colorectal tumors (LST).
Methods Relevant studies were identified in three electro-
nic databases (PubMed, ISI and Cochrane Central Register).
We considered all clinical studies in which colorectal LST
were treated with endoscopic resection (endoscopic muco-
sal resection [EMR] and/or endoscopic submucosal dissec-
tion [ESD]) and/or transanal minimally invasive surgery
(TEMS). Rates of en-bloc/piecemeal resection, complete
endoscopic resection, R0 resection, curative resection, ad-
verse events (AEs) or recurrence, were extracted. Study
quality was assessed with the Newcastle-Ottawa Scale and
a meta-analysis was performed using a random-effects
model.
Results Forty-nine studies were included. Complete resec-
tion was similar between techniques (EMR 99.5% [95% CI
98.6%-100%] vs. ESD 97.9% [95% CI 96.1–99.2%]), being
curative in 1685/1895 (13 studies, pooled curative resec-
tion 90%, 95% CI 86.6–92.9%, I2 = 79%) with non-signifi-
cantly higher curative resection rates with ESD (93.6%,
95 % CI 91.3–95.5%, vs. 84% 95% CI 78.1–89.3% with
EMR). ESD was also associated with a significantly higher
perforation risk (pooled incidence 5.9%, 95% CI 4.3–7.9%,
vs. EMR 1.2%, 95% CI 0.5–2.3%) while bleeding was signif-
icantly more frequent with EMR (9.6%, 95% CI 6.5–13.2%;
vs. ESD 2.8%, 95% CI 1.9–4.0%). Procedure-related mortal-
ity was 0.1%. Recurrence occurred in 5.5%, more often with
EMR (12.6%, 95% CI 9.1–16.6% vs. ESD 1.1%, 95% CI 0.3–
2.5%), with most amenable to successful endoscopic treat-
ment (87.7%, 95% CI 81.1–93.1%). Surgery was limited to
2.7% of the lesions, 0.5% due to AEs. No data of TEMS were
available for LST.
Conclusions EMR and ESD are both effective and safe and
are associated with a very low risk of procedure related
mortality.
Original article
* Drs. Russo and Barbeiro: These authors contributed equally.
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is of paramount importance to establish an unambiguous and
consensual definition for these lesions.
LST tend to preferentially spread superficially along the colo-
nic wall rather than invading the submucosal layer and endo-
scopic resection can be effectively used as a minimally invasive
treatment for the majority [4]. The flat morphology and poten-
tially large dimensions of LST may render complete resection
challenging [4]. The most common treatment approach for
LST is endoscopic mucosal resection (EMR). However, en-bloc
resection is usually restricted to lesions of less than 20mm di-
ameter. Piecemeal EMR of larger lesions is usually safe, but may
hinder histologic assessment and lead to an increased risk of lo-
cal recurrence. Endoscopic submucosal dissection (ESD) may
overcome this problem, allowing dissection of larger lesions in
one piece, although the procedure is technically more difficult,
much more time-consuming, mandates multiday hospital ad-
mission and has an increased risk of perforation [5]. The major-
ity of colorectal superficial lesions can be removed in a curative
way by polypectomy or EMR; nevertheless, ESD should be con-
sidered for the removal of colorectal lesions with high suspicion
of limited submucosal invasion, including those with depressed
morphology or irregular/nongranular surface pattern, particu-
larly in lesions larger than 20mm [6].
Some recent meta-analyses have addressed endoscopic
treatment outcomes of large non-pedunculated colorectal le-
sions and large colorectal polyps [7–9]. However, there are no
published systematic reviews or meta-analyses focusing exclu-
sively on LST.
In this systematic review and meta-analysis, the authors
aimed to evaluate the efficacy and safety outcomes of endo-
scopic treatment of colorectal LST. Since many authors include
purely sessile lesions in the LST group, it was also intended to
study the clinical relevance of distinguishing LST from large ses-
sile colorectal lesions.
Methods
A systematic review was conducted according to the preferred
reporting items for systematic reviews and meta-analyses
(PRISMA) statement [10]. The current systematic review was
structured through the following PICO framework, addressing
patients with LST, submitted to ESD/EMR/TEMS and evaluating
the following outcomes: en-bloc/piecemeal, complete endo-
scopic resection, R0 and curative resections, adverse events
and recurrence.
Eligibility criteria
All clinical studies published before June 15, 2016 in which
colorectal LST were treated with endoscopic resection (EMR
and ESD) and/or transanal minimally invasive surgery were con-
sidered. Only studies that reported at least one of the main
treatment outcomes (en-bloc/piecemeal resection; complete
endoscopic resection; R0 resection; curative resection; AEs or
recurrence), were eligible for inclusion. Prospective and retro-
spective cohort studies, case-control studies and therapeutic
clinical trials were included.
Manuscripts were excluded if they: (1) included sessile le-
sions (Paris 0-Is) and LST in the same group without a sub-anal-
ysis for LST treatment outcome; (2) included fewer than 20 LST
(3) were animal or review studies; or (4) were non-English stud-
ies.
If there was suspicion of patient overlap between studies,
only the study with the largest patient cohort for each of the
outcomes was included.
Definitions
En-bloc resection was defined as resection of the lesion in one
single piece and piecemeal resection as resection in more than
one fragment.
Complete endoscopic resection was defined as the percep-
tion of the endoscopist that the lesion had been completely re-
moved during endoscopy.
The resection was considered as R0 when histopathological
examination confirmed free vertical and lateral margins, as R1
if the resection margins were involved or as Rx if the lateral or
deep margins couldn’t be evaluated due to piecemeal resection
or coagulation effects.
Local recurrence implies that the patients were followed up
for at least one colonoscopy after the index procedure and was
defined as the finding of dysplastic tissue with histopathologi-
cal confirmation detected at the site of previous endoscopic
treatment. Resection was considered curative for adenomatous
lesions or intramucosal carcinoma if R0 resection was achieved
or if there was no recurrence at the end of follow up. For mini-
mally invasive adenocarcinoma (sm1 invasion <1000µm) resec-
tion was considered curative for well-differentiated tumors if
R0 resection was achieved and there was no lymphovascular or
perineural invasion.
Bleeding was classified into two subtypes: immediate and
delayed. Immediate bleeding was defined as active bleeding
that developed during the procedure. Delayed bleeding was de-
fined as melena or bloody stools that occurred after completion
of endoscopic resection. Bleeding was further classified as mi-
nor (when hemostasis required endoscopic procedures – he-
moclip application/injection therapy, without a blood transfu-
sion) or massive (when requiring blood transfusion and/or sur-
gery) [11–15]. Bleeding during the resection procedure that
was stopped spontaneously or with hemostatic forceps was
not considered to be a complication. [5] In most cases, large
visible exposed vessels or bleeding points were coagulated
using hemostatic forceps and any remaining vessels visible
after completed resection were also coagulated routinely to
prevent delayed bleeding.
Perforation was immediate (diagnosed by endoscopic evi-
dence of a definite mural defect with the visualization of an in-
traperitoneal organ or peritoneal/fat tissue) or delayed (diag-
nosed after a finished endoscopic resection by presence of
free air on abdominal plain radiograph or during a computed
tomogram) [11, 12, 14, 15].
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Search strategy
Relevant studies were identified in three electronic databases
(MEDLINE through PubMed; ISI Web of Knowledge and Co-
chrane Central Register of Controlled Trials). The search was
performed using the following query for PubMed: (polyp OR tu-
mor OR tumour OR tumors OR lesion OR neoplasm OR adeno-
ma) AND (non-pedunculated OR large OR flat OR “lateral
spreading”; OR “laterally spreading”; OR LSL OR LST) AND (co-
lon OR rectum OR colorectal OR colorectal OR colonic OR rec-
tal) AND (endoscopic AND (resection OR EMR OR ER OR muco-
sectomy OR endoscopic submucosal dissection OR ESD OR po-
lypectomy OR transanal endoscopic microsurgery OR TEMS OR
TEM OR TAMIS OR “transanal surgery”). The search terms for
other databases were adapted from this query. Additional stud-
ies were identified by checking the list of references of all in-
cluded studies and also review articles on this topic. The last
search was performed on June 15, 2016.
Study selection
After removal of duplicates, two authors (PR, SB) independent-
ly screened all titles and abstracts for relevance. The full text of
selected relevant studies was then evaluated by the same two
researchers according to the inclusion criteria described above.
A third author (MDR) intervened in case of disagreement.
Quality evaluation and data extraction
Data extraction was performed by PR, SB and HA. Another two
reviewers (MDR and MJB) independently checked the extracted
data and disagreements were solved by consensus.
From each paper the following data were collected: (1)
country; (2) publication year; (3) setting (single-center/multi-
center); (4) enrollment period; (5) study design (prospective/
retrospective); (6) type of resection techniques (EMR/ESD/
TEMS); (7) operator (single/multiple; experienced/non-experi-
enced); (8) definition of LST; (9) number of LST; (10) number
of patients with LST; (11) mean/median age of the patients
with LST; (12) gender distribution; (13) morphology of LST and
subtypes (LSTG/LSTNG and LSTGH/LSTGM/LSTNGF/LSTNGPD);
(14) mean size of LST; (15) size distribution (number of
≥ 10 mm/≥20mm/≥30mm/≥40mm); (16) site distribution
(proximal/distal); (17) type of resection (en-bloc/piecemeal);
(18) rate of complete endoscopic resection; (19) histology (R0
and curative resection); (20) rate of AE (bleeding, perforation,
death, other); (21) average follow-up period (months); (22)
rate of recurrence; (23) treatment of recurrence; and (24) rate
of surgery (for unsuccessful complete resection, for non-cura-
tive resection, for AE or for recurrence).In some articles, added
additional data provided by the authors were added.
Quality evaluation was performed by PR and HA using the
Newcastle-Ottawa scale.
Data synthesis and statistical analysis
Raw data for each outcome (number of events and total) were
collected allowing calculation of outcome prevalence and
standard error. For meta-analysis, as most of the studies report
prevalence rates between 0% and 100% (depending on the
evaluated outcome), the double arcsine transformation (Free-
man-Tukey) was used to adjust for variance. Double arcsine
transformed proportions were then used for calculation of
pooled proportions and were back-transformed for results pre-
sentation to allow easier interpretation.
Meta-analysis was performed with MetaXL and Open Meta-
analyst using a random-effect model and heterogeneity was
evaluated with Cochran’s Q test and I2, a measure of inconsis-
tency. A subgroup analysis was planned according to the resec-
tion method used (EMR or ESD). Sensitivity analysis was per-
formed when substantial heterogeneity was detected. Publica-
tion bias was assessed visually with funnel plot for the primary
outcome.
Results
Study selection
A total of 2819 studies were identified by the searches in
PubMed (1666), ISI (1023) and Cochrane Register of Controlled
Trials (130). After screening titles and abstracts, 873 studies
were found to be eligible. After full-text analysis, 824 studies
were excluded (812 did not fill the inclusion criteria; 10 had
Combined results   3735
Results (titles and abstracts)
Pubmed 1666 ISI 1023 Cochrane 130 
Results (full text)
Pubmed 425 ISI 434 Cochrane 14 
49 final results
*Cochrane trials database
PubMed results
1666
ISI results
1892
Cochrane 
results 177*
Removing duplicates
Screening title and abstract – exclusion:
▪ Animal studies
▪ Not English, Portuguese or Spanish languages
▪ Not colon and/or rectum
▪ Not clinical study (case reports, reviews,
 meta-analyses) 
Screening full text – exclusion:
▪ Not LST group
▪ Not at least one treatment outcome
▪ Not adenoma and/or T1 cancer and/or serrated
▪ N < 20
▪ Excluded familial polyposis syndrome,
 inflammatory bowel disease 
▶ Fig. 1 Flow chart of the selection of studies eligible for data ex-
traction and analysis.
Russo Pedro et al. Management of colorectal… Endoscopy International Open 2019; 07: E239–E259 E241
Th
is
 d
oc
um
en
t w
as
 d
ow
nl
oa
de
d 
fo
r p
er
so
na
l u
se
 o
nl
y.
 U
na
ut
ho
riz
ed
 d
ist
rib
ut
io
n 
is 
st
ric
tly
 p
ro
hi
bi
te
d.
▶ Table 1 The main characteristics of the included studies.
Period of enroll-
ment, years
Number
of LST
Size of LST included, mm Technical modifications Quality1
EMR
Prospective, multicenter
Australia
Burgess NG, 2014 [69] 2008–2013 873 ≥20 7
Moss A, 2015 2008–2012 747 ≥20 6
Italy
Conio M, 2010 [16] 2000–2007 136 ≥20 Cap EMR 6
Greece
Fasoulas K, 2012 [18] 2005–2010 49 ≥30 RCT
Czech
Urban O, 2008 [4] 2002–2006 138 >10 6
Prospective, single-center
Germany
Belle S, 2012 [25] 2006–2007 70 >12 STEP EMR 6
Retrospective, single center
Japan
Yoshikane H, 1999 [17] 1996–1998 23 NR Cap EMR 8
Uraoka T, 2005 [14] 1998–2003 223 ≤30 6
Tanaka,2001 [70] NR 120 ≥20 6
Tamura S, 2004 [71] 1989–2002 67 NR 6
China
Huang Y, 2009 [38] 2000–2007 111 ≥10 6
Taiwan
Su MY, 2008 [72] 1999–2005 201 >10 6
UK
Hurlstone DP, 2004 [73] 1999–2003 82 ≥10 6
Arebi N, 2007 [27] 1997–2005 48 ≥20 6
United States
Kim HG, 2014 [26] 2009–2014 80 LST≥20 Underwater EMR 7
Binmoller KF, 2015 [19] NR 53 >20 and< 40 Underwater EMR 5
ESD
Prospective, single-center
Japan
Ritsuno H, 2014 [53] 2010–2011 50 >20 ESD S-O clip traction RCT
Retrospective, multicenter
Japan
Mizushima T, 2015 [54] 2011–2013 113 NR 6
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▶ Table 1 (Continuation)
Period of enroll-
ment, years
Number
of LST
Size of LST included, mm Technical modifications Quality1
Retrospective, single center
Japan
Uraoka T, 2010 [56] 2006–2008 37 LSTG≥30 and LSTNG≥20 8
Okamoto K, 2012 [59] 2010–2011 30 >20 LSTNG;
> 30 LSTG
Traction vs. no traction 7
Suzuki S, 2014 [13] 2009–2013 290 NR 6
Niimi K, 2010 [11] 2000–2008 245 NR 6
Nishiyama H, 2010 [12] 2002–2008 204 >20 6
Hotta K, 2012 [58] 2000–2010 201 NR 6
Hisabe T, 2012 [57] 2003–2011 162 NR 6
Sakamoto T, 2014 [49] 2005–2012 139 >20 6
Nawata Y, 2014 [61] 2010–2013 137 18–123 6
Toyonaga T, 2010 [55] 2009–2010 132 NR 6
Makino T, 2015 [62] 2009–2013 58 >10 5
Okamoto K, 2013 [60] 2010–2012 30 28–45 M2-SB 5
Korea
Bae JH, 2015 [15] 2007–2014 153 ≥30 ESD and ESD with snaring 8
EJ Lee 2011 [63] 2006–2010 358 ≥20 7
Hong MJ, 2015 [65] 2010–2013 113 >20 7
Jung DH, 2015 [66] 2009–2014 163 NR (subgroup≥100) 6
Yoon JY, 2012 [64] 2008–2011 101 ≥10 6
Kim ES, 2011 [23] 2007–2009 81 ≥10 6
China
Xu MD, 2013 [41] 2008–2011 137 ≥20 8
Cong ZJ, 2015 [36] 2003–2007 177 ≥30 7
Zhou PH, 2009 [67] 2006–2007 74 ≥20 6
Tang XW, 2016 [30] 2010–2014 36 ≥40 5
Turkey
Hulagu S, 2013 [20] 2006–2011 44 ≥20 5
Austria
Berr F, 2014 [24] 2009–2012 39 ≥20 5
UK
Hurlstone DP, 2007 [22] 2004–2006 28 ≥20 6
Germany
Probst A, 2012 [5] 2004–2011 74 >15 9
Italy
Repici A, 2013 [68] 2010–2011 40 33–80 6
ESD vs. EMR
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risk of patient overlap; two due to conflicting data) while 49
studies were included. A flow chart of the selection process is
shown in ▶Fig. 1.
Study characteristics
The main characteristics of the included studies are listed in
▶Table1. Most of the studies were single-center (43, 87.8%),
and six (12.2%) were multicenter. The majority (42, 85.7%)
were retrospective. Sixteen studies evaluated EMR, including
two studies of cap-assisted EMR and two studies including un-
derwater EMR (one them for recurrent LST); 29 studies report-
ed one or more outcomes for ESD; four studies reported out-
comes for both techniques. A total of 27 studies included exclu-
sively laterally spreading tumors, while a sub-analysis for LST
was available in the other 22 studies.
Inclusion criteria regarding lesion size varied between the
studies: lesions ≥10mm – 7 studies; ≥12mm – 1 study;
≥15mm – 1 study; 20 studies included lesions ≥20mm (one of
them ≤40mm); 3 studies included lesions ≥30mm and one
≥ 40 mm; 2 studies included LST-NG ≥20mm and LST-G
≥30mm; one study included lesions ≤30 mm; the other studies
did not specify inclusion criteria based on size.
En-bloc/piecemeal resection was reported in 12 EMR and 17
ESD studies. Complete endoscopic resection according to our
definition was available in 20 studies (8 EMR and 12 ESD). R0
rates were assessed in three EMR and 14 ESD studies, while
data on the recurrence was given in 15 EMR and 15 ESD studies.
We could extrapolate curative resection according to our crite-
ria in six EMR and eight ESD studies. Twelve studies reported
global AE rate for EMR; 13 reported perforation and 14 bleed-
ing. The same information was available for ESD in 21, 25 and
19 studies, respectively.
Information regarding surgical intervention was available in
16 EMR studies (12 for surgery of recurrence; 14 for AE and 12
for incomplete/non-curative resection) and 21 ESD studies (11
for recurrence, 19 for AEs and 10 for incomplete/non-curative
resection).
En-bloc resection
Overall, pooled en-bloc resection rate was 75.6% (95% CI
60.4 %-88.2%, I2 = 99%), being significantly higher with ESD
(93.7%, 95% CI 89.3–95.6%)– versus EMR (37.7%, 95% CI
23.0%–53.5%) (▶Fig. 2a). Conio M. et al. [16] applied the
cap-assisted EMR technique in all of the lesions (≥20mm)
which explains the 0% en-bloc resection in this study. The study
by Yoshikane H. et al. [17] also evaluated cap-assisted EMR but
included lesions ≥10mm, allowing 65.2% en-bloc resection.
The lower en-bloc rate in Fasoulas K. et al. [18], is explained by
the inclusion of larger lesions (≥30mm). In contrast, Binmoller
K.F. et al. [19], resected 55% of the lesions (20–40mm) en-bloc
using the underwater EMR technique. The two studies with
lower ESD en-bloc rate were Hulagu S. et al. and Iizuka H. et al.
[20, 21]. Hulagu S. et al. [20], justified their lower rate of en-
bloc resection with the higher rate of partial prior endoscopic
resection (polypectomy) and scar tissue formation. The high
rate of deep submucosal cancer may have precluded better re-
sults in the Lizuka et al. study [21]. En-bloc resection rates were
not significantly different for LST-G and LST-NG for both ESD
and EMR (ESD: 11 studies, OR 0.837 95% CI 0.534–1.312, I2 =
0%; EMR: 4 studies, OR 0.529 95% CI 0.410–0.683, I2 = 25%).
The rate of en-bloc resection in EMR studies was not signifi-
cantly different in studies including lesions > 10mm and
> 20 mm; only two studies using the 30-mm threshold were
found and the rate of en-bloc resection was significantly higher
in the Study including lesions < 30mm (53,8% 95% CI 47.2–
60.3% versus 22.4% 95% CI 11.7–35.3%). The rate of ESD en-
bloc resection was not influenced by the size of the lesions in-
cluded, being>90% in all subgroups ( > 20 mm: 6 studies, 92.8%
95% CI 86.8–97.5%; > 30 mm: 4 studies, 91.9% 95% CI 83.9–
98.1%; > 40 mm: 1 study, > 100 mm: 1 study, 93.3 95% CI 88–
96.7%; not reported: 5 studies, 93.5% 95% CI 85.2–99.5%). In
a subgroup analysis, according to the size of included lesions,
the rate of en-bloc resection was significantly higher in ESD
studies whether they included lesions > 20mm or >30mm.
▶ Table 1 (Continuation)
Period of enroll-
ment, years
Number
of LST
Size of LST included, mm Technical modifications Quality1
Retrospective, single center
Japan
Iizuka H,2009 [21] 2000–2004 70 ≥20 7
Terasaki, 2011 [74] 2006–2009 267 >20 ESD/hybridESD vs. EMR/EMRP 6
India
Tajika M, 2011 [75] 1995–2009 106 >20 7
UK
Hurlstone DP, 2006 [52] 1999–2004 20 16–58 Salvage EMR/ESD 6
1 Quality evaluation using Newcastle-Ottawa scale. NR-not reported.
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Complete resection and R0 resection
Complete endoscopic resection by endoscopist opinion was
achieved in 98.6% (95% CI 97.6–99.4%, I2 = 58%), being similar
with EMR and ESD (▶Fig. 2b). Pooled R0 resection was 79.2%
(95% 68.3–88.4%, I2 = 79.2), being significantly higher with
ESD (86.4% 95% CI 79.5–91.7% vs. EMR 36.2% 95% CI 31.2–
41.8%), Once again the study by Lizuka, 2009, showed lower
ESD complete endoscopic and R0 resection rates, possibly be-
cause of the high incidence of deep submucosal invasion [21].
In the Hurlstone ESD study [22], a low R0 rate (67,9%) is in cor-
relation with a low en-bloc rate (78,6%– includes non-LST le-
sions).
There were no statistically significant differences between
R0 resection for LST-G and LST-NG (OR 1.082 CI 0.770–1.519,
I2 0%). R0 resection was achieved in 673 /763 (83.5%) of LST-G
and 347 /417 (83.2%) of LST-NG (▶Fig. 2c).
Curative resection
Overall, endoscopic resection of LST was curative in 1685/1895
(13 studies, pooled curative resection 90%, 95% CI 86.6–
92.9%, I2 = 79%). Subgroup analysis according to the technique
used showed significantly higher curative resection rates with
ESD (93.6% 95% CI 91.3–95.5%, versus 84% 95% CI 78.1–
89.3% with EMR) (▶Fig. 2d). It is worth highlighting the study
 Study or subgroup En bloc by technique Prev (95 % CI) % Weight
 EMR
 Moss A, 2015  0,164 (0,138, 0,191) 3,6
 Conio M, 2010  0,000 (0,000, 0,013) 3,6
 Fasoulas K, 2012  0,224 (0,117, 0,353) 3,5
 Urban O, 2008  0,470 (0,385, 0,555) 3,6
 Yoshikane H, 1999  0,652 (0,444, 0,836) 3,4
 Uraoka T, 2005  0,538 (0,472, 0,603) 3,6
 Tanaka S, 2001  0,506 (0,397, 0,615) 3,6
 Huang Y, 2009  0,447 (0,351, 0,544) 3,6
 Binmoller KF, 2015  0,547 (0,411, 0,680) 3,6
 Iizuka H (EMR), 2009  0,558 (0,407, 0,704) 3,5
 Terasaki, 2011  0,393 (0,323, 0,466) 3,6
 EMR subgroup  0,376 (0,230, 0,535) 39,3
 Q = 372,71, P = 0,00,
 I2 = 97 %
 ESD
 Ritsuno H, 2014  0,980 (0,916, 1,000) 3,5
 Uraoka T, 2010  1,000 (0,954, 1,000) 3,5
 Niimi K, 2010  0,918 (0,880, 0,950) 3,6
 Nishiyama H, 2010  0,868 (0,817, 0,911) 3,6
 Hotta K, 2012  0,930 (0,890, 0,962) 3,6
 Sakamoto T, 2014  0,957 (0,916, 0,985) 3,6
 Toyonaga T, 2010  1,000 (0,987, 1,000) 3,6
 Okamoto K, 2013  1,000 (0,943, 1,000) 3,5
 Bae JH, 2015  0,928 (0,881, 0,964) 3,6
 Jung DH, 2015  0,933 (0,888, 0,967) 3,6
 Xu MD, 2013  0,985 (0,956, 1,000) 3,6
 Cong ZJ, 2015  0,831 (0,771, 0,882) 3,6
 Zhou PH, 2009  0,932 (0,862, 0,980) 3,6
 Tang XW, 2016  0,917 (0,799, 0,989) 3,5
 Hulagu S, 2013  0,773 (0,636, 0,886) 3,5
 Repici A, 2013  0,900 (0,784, 0,977) 3,5
 Iizuka H (ESD), 2009  0,630 (0,438, 0,804) 3,5
 ESD subgroup  0,937 (0,893, 0,956) 60,7
 Q = 104,45, P = 0,00,
  I2 = 85 %     
 
 Overall  0,756 (0,604, 0,882) 100,0
 Q = 2472,25, P = 0,00
 I2 = 99 %   
 10 Prevalencea
▶ Fig. 2a Rate of en-bloc resection by technique.
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by Fasoulas et al. [18], with the lowest curative resection rates
among the EMR studies that included larger lesions (≥30mm).
Submucosal invasion
Prevalence of cancer was similar between the EMR and the ESD
series, despite the trend towards more submucosal invasion in
the ESD series (EMR 5.6% 95% CI 2.0–10.2% versus ESD 11%
95% CI 5.9–17.0%) (▶Fig. 2e). If we exclude the outliers (stud-
ies with a prevalence of submucosal invasion >20%), (Terasaki
EMR; Uraoka T; Terasaki ESD, Yoon JY) the difference is still not
significant (EMR 4.1% 95% CI 2.3–6.2% versus ESD 5.8% 95%
CI 4.4–9.6%). LST-G presented less submucosal invasion (39/
503) when compared to LST-NG (OR 0.47 95% CI 0.29–0.74).
Adverse events
Resection of LSTs was associated with a pooled incidence of
overall AEs of 9.2% (7.2–11.5%). No significant differences be-
tween EMR and ESD were found (▶Fig. 3a).
Overall, pooled perforation rate was 4.1% (95% CI 2.7–
5.6%, I2 = 84%). However, ESD was associated with a significant-
ly higher perforation risk (pooled incidence 5.9% 95% CI 4.3–
7.9%, versus EMR 1.2% 95% CI 0.5–2.3%) (▶Fig. 3b). The stud-
ies by Kim [23] and Berr [24] registered the larger number of
perforations. The latter study evaluated the untutored learning
of ESD in a series of 50 lesions including 33 colorectal LST and
15.2% of the colorectal procedures were complicated with per-
foration. If this study is excluded the perforation rate is 5.7%.
On the other hand, pooled bleeding rate was 5.3% (95% CI
3.6–7.2%) and was significantly more frequent with EMR
(9.6 % 95% CI 6.5–13.2%; versus ESD 2.8% 95% CI 1.9–4.0%)
 Study or subgroup Complete endoscopic resection by technique Prev (95 % CI) % Weight
 EMR
 Conio M, 2010  1,000 (0,987, 1,000) 6,5
 Fasoulas K, 2012  0,959 (0,881, 0,999) 4,2
 Urban O, 2008  1,000 (0,987, 1,000) 6,4
 Belle S, 2012  0,970 (0,911, 0,999) 4,9
 Huang Y, 2009  1,000 (0,983, 1,000) 5,9
 Binmoller KF, 2015  1,000 (0,968, 1,000) 4,4
 Iizuka H (EMR), 2009  1,000 (0,960, 1,000) 3,9
 Terasaki, 2011  1,000 (0,990, 1,000) 7,0
 EMR subgroup  0,995 (0,986, 1,000) 43,2
 Q = 10,50, P = 0,16,
 I2 = 33 %
 ESD
 Ritsuno H, 2014  1,000 (0,966, 1,000) 4,3
 Okamoto K, 2012  0,900 (0,762, 0,986) 3,1
 Hotta K, 2012  0,970 (0,941, 0,990) 7,2
 Toyonaga T, 2010  1,000 (0,987, 1,000) 6,4
 Makino T, 2015  0,983 (0,927, 1,000) 4,6
 Okamoto K, 2013  1,000 (0,943, 1,000) 3,1
 Bae JH, 2015  0,987 (0,961, 1,000) 6,7
 Zhou PH, 2009  1,000 (0,977, 1,000) 5,2
 Hulagu S, 2013  0,977 (0,905, 1,000) 4,0
 Repici A, 2013  1,000 (0,957, 1,000) 3,8
 Iizuka H (ESD), 2009  0,815 (0,643, 0,942) 2,9
 Terasaki (ESD), 2011  0,978 (0,935, 1,000) 5,6
 ESD subgroup  0,979 (0,961, 0,992) 56,8
 Q = 27,03, P = 0,00,
  I2 = 59 %     
 Overall  0,986 (0,976, 0,994) 100,0
 Q = 45,48, P = 0,00
 I2 = 58 %   
 
b
0,64
0,66
0,68
0,7
0,72
0,74
0,76
0,78
0,8
0,82
0,84
0,86
0,88
0,9
0,92
0,94
0,96
0,98
1
Prevalence
▶ Fig. 2b Rate of complete endoscopic resection by technique.
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(▶Fig. 3c). Bleeding rate was particularly high in the study by
Belle et al. [25], in which 25/66 patients required hemostasis
with clips. If this atypical study is excluded, the bleeding rate
is 4.8% (95% CI 3.4%-6.5%) and remains significantly higher
with EMR.
If we only consider major bleeding there were no statistically
significant differences between both techniques (EMR 0.2%
95% CI 0–0.04% versus ESD 0.4% 95% CI 0.1–0.7%). Immedi-
ate minor bleeding was significantly less frequent for ESD (0.5%
95% CI 0.1–1.0% versus EMR: 7.7% 95% CI 1.5–15.9%). No dif-
ferences were found between EMR and ESD for delayed major
or minor bleeding.
Coagulation syndrome was evaluated in five studies includ-
ing 718 patients (3 EMR, 1 EMR&ESD and 1 ESD studies) and
pooled rate was 3.1% (95% CI 0.3–8.0%, I2 = 86%).
One patient died following EMR due to complications of
acute myocardial infarction [4]. Pooled procedure-related mor-
tality was 0.1% (95% CI 0.0–0.3%, I2 = 0%).
Between both subtypes of LST there were no differences in
perforation or bleeding rates. In LST-G, perforation occurred in
52/906 (5.74%) while in LST-NG it occurred in 20/446 (4.48%)
(OR 1.072, 95% CI 0.497–2.310, I2 = 36.94%). Bleeding was
more frequent with LST-G (26 /585–4.44%) compared with
LST-NG (11 /424–2.59%) (OR 2.460, 95% CI 0.476–12.729,
I2= 75.05%).
Recurrence
Overall, recurrence occurred in 5.5% (95% CI 3.0–8.6%) being
significantly more frequent with EMR (12.6% 95% CI 9.1–
16.6%) vs. ESD (1.1% 95% CI 0.3–2.5%). However, the majority
of the recurrences were amenable to successful endoscopic
treatment (87.7%, 95% CI 81.1–93.1%). The timing of endo-
scopic surveillance was heterogeneous between the studies
which may have affected the rate of early recurrence. Mean fol-
low-up ranged from 9.2 to 60.8 months.
The retrospective study from Kim et al. evaluated the effica-
cy of underwater versus conventional EMR for the treatment of
recurrence after piecemeal resection of LST [26]. Underwater
EMR was successful in 18/20 patients and conventional EMR
was successful in only 20/33 [26]. Two EMR studies demon-
strated the highest recurrence rates, Arebi N. et al. [27]
(40.9 %, 95% CI 26.7–55.9%) and Fasoulas et al. [18] (27.3%,
95% CI 15.0–41.5%). The latter, probably because larger le-
sions (≥30mm) were included with only 22.4% removed en-
bloc [18].
Surgery rates
Overall, LSTs submitted to endoscopic resection led to surgery
in 2.7% (95% CI 1.8–3.8%), without significant differences in
surgery rates according to the endoscopic resection technique
despite a trend to higher surgery rates with EMR (▶Fig. 4a).
Concerning the reasons for surgery:
▪ 33 studies involving 3857 patients reported 12 surgeries due
to AEs (pooled rate was 0.5%, 95% CI 0.3–0.7%, I2 = 0%);
there was no difference in surgery due to AEs between the
ESD and the EMR group.
 Study Complete histological resection (LST-g vs LST-ng) OR (95 % CI) % Weight
 Toyonaga T, 2010  1,533 (0,030, 78,474) 0,7
 Niimi K, 2010  1,324 (0,741, 2,365) 34,3
 Nishiyama H, 2010  0,814 (0,380, 1,744) 19,9
 Iizuka H, 2009  3,333 (0,263, 42,212) 1,8
 Okamoto K, 2013  1,696 (0,031, 91,392) 0,7
 Hotta K, 2012  0,746 (0,332, 1,674) 17,7
 Cong ZJ, 2015  0,852 (0,366, 1,982) 16,2
 Xu MD, 2013  2,447 (0,473, 12,670) 4,3
 Hurlstone Dp, 2007  2,143 (0,428, 10,738) 4,4
 Overall  1,082 (0,770, 1,519) 100,0
 Q = 4,59, P = 0,80,
 I2 = 0 %
c
0 13,4 26,8 40,2 53,6 67
OR
▶ Fig. 2c Rate of complete endoscopic resection by type of lesion.
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 Study or subgroup Submucosal invasion by technique Prev (95 % CI) % Weight
 EMR
 Moss A, 2015  0,053 (0,038, 0,070) 4,0
 Urban O, 2008  0,037 (0,010, 0,076) 3,8
 Belle S, 2012  0,029 (0,000, 0,084) 3,6
 Yoshikane H, 1999  0,000 (0,000, 0,074) 2,9
 Tanaka, 2001  0,086 (0,033, 0,159) 3,6
 Tamura S, 2004  0,090 (0,031, 0,172) 3,6
 Su MY, 2008  0,080 (0,046, 0,123) 3,9
 Hurlstone DP, 2004  0,000 (0,000, 0,029) 3,5
 Binmoller KF, 2015  0,000 (0,000, 0,032) 3,4
 Terasaki, 2011 (EMR)  0,281 (0,217, 0,349) 3,9
 EMR subgroup  0,056 (0,020, 0,102) 36,1
 Q = 90,90, P = 0,00,
 I2 = 90 %
 ESD
 Ritsuno H, 2014  0,080 (0,018, 0,174) 3,4
 Uraoka T, 2010  0,676 (0,515, 0,818) 3,2
 Niimi K, 2010  0,143 (0,102, 0,190) 3,9
 Nishiyama H, 2010  0,069 (0,037, 0,108) 3,9
 Sakamoto T, 2014  0,158 (0,102, 0,224) 3,8
 Makino T, 2010  0,155 (0,072, 0,261) 3,5
 Bae JH, 2016  0,072 (0,036, 0,119) 3,8
 Yoon JY, 2012  0,277 (0,194, 0,369) 3,7
 Xu MD, 2013  0,080 (0,040, 0,132) 3,8
 Cong ZJ, 2015  0,073 (0,039, 0,117) 3,9
 Zhou PH, 2009  0,043 (0,006, 0,107) 3,6
 Tang XW, 2016  0,000 (0,000, 0,047) 3,2
 Hulagu S, 2013  0,000 (0,000, 0,039) 3,3
 Berr F, 2014  0,000 (0,000, 0,044) 3,3
 Hurlstone DP, 2007  0,000 (0,000, 0,061) 3,0
 Probst A, 2012  0,081 (0,028, 0,156) 3,6
 Repici A, 2013  0,050 (0,001, 0,145) 3,3
 Terasaki, 2011 (ESD)  0,539 (0,435, 0,642) 3,7
 ESD subgroup  0,110 (0,059, 0,170) 63,9
 Q = 222,71, P = 0,00,
 I2 = 92 %
 Overall  0,088 (0,055, 0,128) 100,0
Q = 337,78, P = 0,00,
 I2 = 92 %
d
0 0,2 0,4 0,6 0,8
Prevalence
▶ Fig. 2d Rate of curative resection according to technique.
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 Study or subgroup Recurrence by technique Prev (95 % CI) % Weight
 EMR
 Moss A, 2015  0,139 (0,112, 0,168) 3,9
 Conio M, 2010  0,024 (0,003, 0,060) 3,7
 Fasoulas K, 2012  0,273 (0,150, 0,415) 3,2
 Urban O, 2008  0,136 (0,083, 0,201) 3,7
 Yoshikane H, 1999  0,045 (0,000, 0,185) 2,7
 Uraoka T, 2005  0,104 (0,063, 0,153) 3,8
 Tanaka, 2001  0,077 (0,026, 0,148) 3,5
 Tamura S, 2004  0,104 (0,041, 0,191) 3,5
 Huang Y, 2009  0,139 (0,071, 0,225) 3,5
 Hurlstone DP, 2004  0,172 (0,085, 0,282) 3,4
 Arebi N, 2007  0,409 (0,267, 0,559) 6,2
 Binmoller K, 2015  0,047 (0,001, 0,135) 3,2
 Terasaki, (EMR), 2011  0,080 (0,044, 0,125) 3,8
 Tajika M (EMR), 2011  0,171 (0,062, 0,317) 3,1
 EMR subgroup  0,126 (0,091, 0,166) 48,3
 Q = 58,39, P = 0,00,
 I2 = 78 %
 ESD
 Ritsuno H, 2014  0,000 (0,000, 0,038) 3,2
 Nishiyama H, 2010  0,000 (0,000, 0,008) 3,8
 Makino T, 2015  0,000 (0,000, 0,030) 3,4
 Bae JH, 2015  0,000 (0,000, 0,011) 3,7
 Jung DH, 2015  0,000 (0,000, 0,011) 3,8
 Xu MD, 2013  0,008 (0,000, 0,036) 3,7
 Cong ZJ, 2015  0,077 (0,038, 0,128) 3,7
 Zhou PH, 2009  0,000 (0,000, 0,023) 3,5
 Tang XW, 2016  0,065 (0,001, 0,185) 3,0
 Hulagu S, 2013  0,047 (0,001, 0,135) 3,2
 Berr F, 2014  0,061 (0,001, 0,174) 3,0
 Probst A, 2012  0,000 (0,000, 0,025) 3,5
 Repici A, 2013  0,026 (0,000, 0,110) 3,1
Terasaki M (ESD), 2011  0,000 (0,000, 0,019) 3,6
 Tajika M (ESD), 2011  0,000 (0,000, 0,024) 3,5
 ESD subgroup  0,011 (0,003, 0,025) 51,7
 Q = 43,73, P = 0,00,
 I2 = 68 %
 Overall  0,055 (0,030, 0,086) 100,0
 Q = 296,82, P = 0,00,
 I2 = 91 %
e
0 0,05 0,1 0,2 0,3 0,4 0,50,15 0,25 0,35 0,45 0,55
Prevalence
▶ Fig. 2e Submucosal invasion by technique.
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▪ 23 studies involving 2257 patients reported eight surgeries
due to recurrences detected during follow up (pooled rate
was 0.5%, 95% CI 0.2–0.8%, I2 = 0%) (▶Fig. 4b). There was
no significant difference between the two techniques.
▪ 21 studies involving 2799 lesions reported 125 surgeries due
to incomplete/non-curative resection (pooled rate was 4.3%,
95% CI 3.3–5.5%, I2 = 44%). No significant difference be-
tween EMR and ESD was found (pooled rate EMR was 3.9%,
95% CI 2.5–5.5%, I2 = 55% vs. pooled rate ESD was 4.6%,
95% CI 3.0–6.3%, I2 = 30%) (▶Fig. 4c).
Publication bias
Visual inspection of the funnel plot and doi plot analysis (LFK in-
dex 0.14 – absence of asymmetry) suggests the absence of
publication bias for the primary endpoint (curative resection).
Discussion
According to our analysis, both EMR and ESD were effective and
safe with a low risk of procedure-related morbidity and rare
mortality. Cure from the primary intervention was more fre-
quently achieved with ESD (93.6% vs. 84% for EMR) with higher
recurrence among patients submitted to EMR (12.6% vs. 1.1%
for ESD) but the endoscopic treatment of recurrence was highly
effective (87.7%). We found no difference in surgery between
both techniques due to incomplete endoscopic/histologic re-
section or recurrence.
The rate of AEs was low and most complications could be
managed endoscopically, as shown by a surgery rate for AEs of
0.3%. Clearly both techniques are very safe. Risk of perforation
was significantly higher for ESD (5.9% vs. 1.2% for EMR) and risk
of bleeding was statistically greater with EMR (9.6% vs. 2.8% for
ESD), but major bleeding and delayed bleeding rates were sim-
ilar for both techniques.
In this meta-analysis, we exclusively included LSTs according
to the accepted definition of flat laterally spreading lesions >
than 10mm. These lesions often cannot be reliably excised en-
bloc by conventional snare polypectomy, especially if larger
than 20mm. In this study, we have examined the interface be-
tween the two available therapeutic techniques of EMR and
ESD. This study evaluates outcomes in a defined, discrete and
 Study or subgroup Curative by technique Prev (95 % CI) % Weight
 EMR
 Moss A, 2015  0,861 (0,832, 0,888) 9,3
 Conio M, 2010  0,853 (0,788, 0,908) 7,9
 Fasoulas K, 2012  0,612 (0,471, 0,745) 5,8
 Huang Y, 2009  0,861 (0,775, 0,929) 6,9
 Hurlstone DP, 2004  0,828 (0,718, 0,915) 6,2
 Terasaki (EMR), 2011  0,921 (0,877, 0,957) 8,3
 EMR subgroup  0,840 (0,781, 0,893) 44,5
 Q = 23,91, P = 0,00,
 I2 = 79 %
 ESD
 Nishiyama H, 2010  0,917 (0,874, 0,951) 8,4
 Makino T, 2015  0,983 (0,927, 1,000) 6,2
 Jung DH, 2015  0,920 (0,873, 0,958) 8,2
 Xu MD, 2013  0,905 (0,850, 0,949) 7,9
 Zhou PH, 2009  0,957 (0,893, 0,994) 6,6
 Hulagu S, 2013  0,955 (0,868, 0,999) 5,6
 Repici A, 2013  0,925 (0,819, 0,990) 5,4
Terasaki M (ESD), 2011  0,978 (0,935, 1,000) 7,2
 ESD subgroup  0,936 (0,913, 0,955) 55,5
 Q = 9,90, P = 0,19,
 I2 = 29 %
 Overall  0,900 (0,866, 0,929) 100,0
 Q = 61,15, P = 0,00,
 I2 = 79 %
f
0,45 0,5 0,55 0,65 0,75 0,85 0,950,6 0,7 0,8 0,9 1
Prevalence
▶ Fig. 2f Recurrence rate by technique.
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well characterized subgroup of large colorectal neoplasms and
is substantially different from previous work [7, 28, 29].
Hassan et al. assessed efficacy and safety of endoscopic re-
section of large colorectal lesions (> 20mm) [7]. Broadly classi-
fied as sessile, pedunculated or non-polypoid, in this study, all
types of tissue resection techniques including conventional po-
lypectomy (26%) were included. Consequently, there is relative
data heterogeneity and the results are thus hard to interpret.
Detailed morphological features are not described and thus
the influence of morphology outcomes was not evaluated. Paris
classification and surface morphology (granular/non-granular)
were not assessed. Endoscopic tissue resection has continuous-
 Study or subgroup Adverse events by technique Prev (95 % CI) % Weight
 EMR
 Moss A, 2015  0,072 (0,055, 0,092) 3,9
 Conio M, 2010  0,103 (0,057, 0,160) 3,4
 Fasoulas K, 2012  0,204 (0,101, 0,330) 2,6
 Urban O, 2008  0,121 (0,070, 0,183) 3,4
 Belle S, 2012  0,470 (0,350, 0,591) 2,9
 Yoshikane H, 1999  0,087 (0,002, 0,245) 1,9
 Uraoka T, 2005  0,094 (0,059, 0,136) 3,6
 Tanaka, 2001  0,173 (0,097, 0,264) 3,0
 Tamura S, 2004  0,015 (0,000, 0,063) 2,9
 Huang Y, 2009  0,107 (0,054, 0,175) 3,2
 Hurlstone DP, 2004  0,103 (0,036, 0,197) 2,8
 Binmoller KF, 2015  0,038 (0,001, 0,110) 2,7
 EMR subgroup  0,122 (0,078, 0,170) 36,2
 Q = 77,58, P = 0,00,
 I2 = 86 %
 ESD
 Ritsuno H, 2014  0,020 (0,000, 0,084) 2,6
 Mizushima T, 2015  0,053 (0,018, 0,103) 3,3
 Uraoka T, 2010  0,027 (0,000, 0,113) 2,3
 Okamoto K, 2012  0,033 (0,000, 0,138) 2,1
 Suzuki S, 2014  0,045 (0,024, 0,072) 3,7
 Niimi K, 2010  0,065 (0,037, 0,100) 3,7
 Nishiyama H, 2010  0,108 (0,069, 0,154) 3,6
 Hotta K, 2012  0,075 (0,042, 0,116) 3,6
 Hisabe T, 2012  0,086 (0,047, 0,135) 3,5
 Nawata Y, 2013  0,000 (0,000, 0,013) 3,4
 Okamoto K, 2013  0,000 (0,000, 0,057) 2,1
 Bae JH, 2015  0,124 (0,076, 0,182) 3,4
 Jung DH, 2015  0,110 (0,066, 0,164) 3,5
 Kim ES, 2011  0,247 (0,158, 0,347) 3,0
 Xu MD, 2013  0,058 (0,024, 0,105) 3,4
 Cong ZJ, 2015  0,056 (0,027, 0,096) 3,5
 Zhou PH, 2009  0,095 (0,037, 0,173) 3,0
 Tang XW, 2016  0,139 (0,042, 0,274) 2,3
 Hulagu S, 2013  0,136 (0,048, 0,256) 2,5
 Probst A, 2012  0,176 (0,094, 0,277) 2,9
 Repici A, 2013  0,075 (0,010, 0,181) 2,4
 ESD subgroup  0,078 (0,056, 0,102) 63,8
 Q = 87,12, P = 0,00,
  I2 = 77 %     
 
 Overall  0,092 (0,072, 0,115) 100,0
 Q = 172,32, P = 0,00
 I2 = 81 %   
 0 0,05 0,1 0,15 0,2 0,3 0,4 0,5 0,60,25 0,35 0,45 0,55
Prevalencea
▶ Fig. 3a Adverse events. Overall adverse events by technique.
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 Study or subgroup Perforation by technique Prev (95 % CI) % Weight
 EMR
 Moss A, 2015  0,004 (0,000, 0,010) 3,3
 Conio M, 2010  0,000 (0,000, 0,013) 2,9
 Fasoulas K, 2012  0,020 (0,000, 0,086) 2,3
 Urban O, 2008  0,038 (0,011, 0,078) 2,9
 Belle S, 2012  0,076 (0,022, 0,154) 2,5
 Yoshikane H, 1999  0,043 (0,000, 0,178) 1,7
 Uraoka T, 2005  0,004 (0,000, 0,019) 3,1
 Tanaka S, 2001  0,012 (0,000, 0,052) 2,6
 Huang Y, 2009  0,000 (0,000, 0,017) 2,8
 Hurlstone DP, 2004  0,000 (0,000, 0,029) 2,4
 Arebi N, 2007  0,000 (0,000, 0,036) 2,3
 Binmoller KF, 2015  0,000 (0,000, 0,032) 2,4
 Terasaki (EMR), 2011  0,017 (0,002, 0,042) 3,0
 EMR subgroup  0,012 (0,005, 0,023) 34,1
 Q = 26,89, P = 0,01,
 I2 = 55 %
 ESD
 Ritsuno H, 2014  0,020 (0,000, 0,084) 2,3
 Mizushima T, 2015  0,053 (0,018, 0,103) 2,8
 Uraoka T, 2010  0,027 (0,000, 0,113) 2,1
 Okamoto K, 2012  0,033 (0,000, 0,138) 1,9
 Niimi K, 2010  0,045 (0,022, 0,075) 3,1
 Nishiyama H, 2010  0,098 (0,061, 0,143) 3,1
 Hotta K, 2012  0,045 (0,020, 0,079) 3,0
 Hisabe T, 2012  0,086 (0,047, 0,135) 3,0
 Sakamoto T, 2014  0,036 (0,010, 0,075) 2,9
 Nawata Y, 2014  0,000 (0,000, 0,013) 2,9
 Makino T, 2015  0,017 (0,000, 0,073) 2,4
 Okamoto K, 2013  0,000 (0,000, 0,057) 1,9
 Bae JH, 2015  0,092 (0,050, 0,143) 2,9
 Lee EJ, 2011  0,095 (0,067, 0,128) 3,2
 Jung DH, 2015  0,086 (0,047, 0,134) 3,0
 Yoon JY, 2012  0,089 (0,040, 0,154) 2,8
 Kim ES, 2011  0,247 (0,158, 0,347) 2,6
 Xu MD, 2013  0,022 (0,003, 0,055) 2,9
 Cong ZJ, 2015  0,023 (0,005, 0,051) 3,0
 Zhou PH, 2009  0,081 (0,028, 0,156) 2,6
 Tang XW, 2016  0,083 (0,011, 0,201) 2,1
 Hulagu S, 2013  0,045 (0,001, 0,132) 2,2
 Berr F, 2014  0,152 (0,046, 0,297) 2,0
 Probst A, 2012  0,074 (0,021, 0,150) 2,5
 Teraski (ESD), 2011  0,022 (0,000, 0,067) 2,7
 ESD subgroup  0,059 (0,043, 0,079) 65,9
 Q = 93,96, P = 0,00,
  I2 = 74 %     
 Overall  0,041 (0,027, 0,056) 100,0
 Q = 227,83, P = 0,00
 I2 = 84 %   
 0 0,05 0,1 0,2 0,30,15 0,25 0,35
Prevalenceb
▶ Fig. 3b Adverse events. Perforation by technique.
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ly developed and improved over time, particularly in the last 10
years. Hassan et al. included eight studies before 2000 which
may have substantially influenced the outcomes of the analysis
[7]. The main outcome of this study was the rate of subsequent
surgery for all reasons. The surgery rate was 8.3%, among these
0.5% due to AEs and 7.8% due to non-curative resections. In our
study, of LSTs excised by EMR or ESD, the rate of post-endo-
scopic resection surgery was 2.7%. In pooled rate analysis of
our data, surgery due to non-curative endoscopic resection,
AEs and recurrence were 4.2%, 0.5% and 0.5% respectively.
Overall AEs were 9.2%, perforations accounted for 4.1% and
bleeding was 5.3%.
Overall the recurrence rate in our study was 5.5% which is
lower than reported in other studies. Hassan et al. reported an
overall recurrence rate of 13.8%, while the recurrence rate
post-EMR versus post-ESD in both studies was 12.7% vs. 1.1%
and 15% vs. 1%, respectively [7]. Belderbos et al. evaluated 33
EMR (>10mm) studies for recurrence rate [28]. The overall re-
 Study or subgroup Bleeding by technique Prev (95 % CI) % Weight
 EMR
 Burgess NG, 2014  0,111 (0,090, 0,134) 3,9
 Conio M, 2010  0,096 (0,051, 0,151) 3,5
 Fasoulas K, 2012  0,143 (0,057, 0,257) 2,8
 Urban O, 2008  0,015 (0,000, 0,045) 3,4
 Belle S, 2012  0,379 (0,265, 0,500) 3,0
 Yoshikane H, 1999  0,043 (0,000, 0,178) 2,0
 Uraoka T, 2005  0,090 (0,055, 0,131) 3,7
 Tanaka, 2001  0,160 (0,088, 0,249) 3,2
 Tamura S, 2004  0,015 (0,000, 0,063) 3,0
 Huang Y, 2009  0,107 (0,054, 0,175) 3,3
 Hurlstone DP, 2004  0,103 (0,036, 0,197) 2,9
 Binmoller KF, 2015  0,019 (0,000, 0,079) 2,8
 Terasaki (EMR), 2011  0,084 (0,047, 0,130) 3,6
 EMR subgroup  0,097 (0,063, 0,134) 41,1
 Q = 69,37, P = 0,00,
 I2 = 83 %
 ESD
 Ritsuno H, 2014  0,000 (0,000, 0,034) 2,8
 Uraoka T, 2010  0,000 (0,000, 0,046) 2,5
 Okamoto K, 2012  0,000 (0,000, 0,057) 2,3
 Suzuki S, 2014  0,045 (0,024, 0,072) 3,7
 Niimi K, 2010  0,020 (0,006, 0,043) 3,7
 Nishiyama H, 2010  0,010 (0,000, 0,029) 3,6
 Hotta K, 2012  0,030 (0,010, 0,059) 3,6
 Nawata Y, 2014  0,000 (0,000, 0,013) 3,5
 Okamoto K, 2013  0,000 (0,000, 0,057) 2,3
 Bae JH, 2015  0,033 (0,009, 0,068) 3,5
 Jung DH, 2015  0,025 (0,005, 0,055) 3,5
 Xu MD, 2013  0,036 (0,010, 0,076) 3,5
 Cong ZJ, 2015  0,028 (0,008, 0,059) 3,6
 Zhou PH, 2009  0,014 (0,000, 0,057) 3,1
 Tang XW, 2016  0,028 (0,000, 0,116) 2,5
 Hulagu S, 2013  0,091 (0,021, 0,197) 2,7
 Probst A, 2012  0,088 (0,030, 0,169) 3,0
 Repici A, 2013  0,050 (0,001, 0,145) 2,6
 Teraski (ESD), 2011  0,115 (0,045, 0,209) 2,9
 ESD subgroup  0,029 (0,019, 0,042) 58,9
 Q = 39,80, P = 0,00,
  I2 = 55 %     
 Overall  0,053 (0,036, 0,073) 100,0
 Q = 199,64, P = 0,00
 I2 = 84 %
0 0,05 0,1 0,2 0,3 0,4 0,50,15 0,25 0,35 0,45
Prevalencec
▶ Fig. 3c Adverse events. Bleeding rate by technique.
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currence rate was as high as 15%, with 3% for en-bloc resec-
tions and 22% for piecemeal resections. Treatment of recur-
rence was successful in 91.4% of the lesions, after a median of
1.2 endoscopic retreatments. Piecemeal resection was the only
risk factor that was clearly associated with recurrence in multi-
variable analysis [28].
In ESD treatment, Puli and Hassan both reported en-bloc
rates of 85% and 50%, respectively [7, 29]. These rates are low-
er than our data (93.7% en-bloc). In our analysis, according to
our predefined and more stringent criteria most of the ESD
studies were from the east.
 Study or subgroup Surgery overall by technique Prev (95 % CI) % Weight
 EMR
 Moss A, 2015  0,051 (0,036, 0,068) 4,1
 Conio M, 2010  0,051 (0,020, 0,096) 3,3
 Fasoulas K, 2012  0,102 (0,030, 0,205) 2,3
 Urban O, 2008  0,061 (0,025, 0,109) 3,2
 Belle S, 2012  0,000 (0,000, 0,026) 2,6
 Uraoka T, 2005  0,009 (0,000, 0,027) 3,6
 Tanaka, 2001  0,037 (0,005, 0,092) 2,8
 Tamura S, 2004  0,060 (0,013, 0,132) 2,6
 Su MY, 2008  0,080 (0,046, 0,121) 3,5
 Huang Y, 2009  0,039 (0,008, 0,087) 3,0
 Hurlstone DP, 2004  0,034 (0,001, 0,101) 2,5
 Arebi N, 2007  0,000 (0,000, 0,036) 2,3
 Binmoller KF, 2015  0,000 (0,000, 0,032) 2,4
 Terasaki (EMR), 2011  0,011 (0,000, 0,034) 3,5
 Hurlstone DP (EMR), 
 2006  0,059 (0,000, 0,236) 1,2
 EMR subgroup  0,037 (0,023, 0,054) 42,9
 Q = 41,42, P = 0,00,
 I2 = 66 %
 ESD
 Ritsuno H, 2014  0,000 (0,000, 0,034) 2,3
 Uraoka T, 2010  0,000 (0,000, 0,046) 2,0
 Suzuki S, 2014  0,000 (0,000, 0,006) 3,7
 Niimi K, 2010  0,008 (0,000, 0,024) 3,7
 Nishiyama H, 2010  0,025 (0,007, 0,051) 3,5
 Hotta K, 2012  0,005 (0,000, 0,021) 3,5
 Makino T, 2015  0,000 (0,000, 0,030) 2,5
 Okamoto K, 2013  0,000 (0,000, 0,057) 1,8
 Jung DH, 2015  0,067 (0,033, 0,112) 3,4
 Yoon JY, 2012  0,000 (0,000, 0,017) 3,0
 Kim ES, 2011  0,000 (0,000, 0,021) 2,8
 Xu MD, 2013  0,073 (0,035, 0,123) 3,3
 Cong ZJ, 2015  0,062 (0,031, 0,103) 3,5
 Zhou PH, 2009  0,014 (0,000, 0,057) 2,7
 Tang XW, 2016  0,028 (0,000, 0,116) 2,0
 Hulagu S, 2013  0,023 (0,000, 0,095) 2,2
 Berr F, 2014  0,030 (0,000, 0,126) 1,9
 Hurlstone DP, 2007  0,000 (0,000, 0,061) 1,7
 Probst A, 2012  0,000 (0,000, 0,025) 2,6
 Repici A, 2013  0,050 (0,001, 0,145) 2,1
 Terasaki (ESD), 2011  0,077 (0,030, 0,142) 2,9
 ESD subgroup  0,020 (0,010, 0,034) 57,1
 Q = 71,97, P = 0,00,
  I2 = 72 %      
 Overall  0,027 (0,018, 0,038) 100,0
 Q = 130,33, P = 0,00
 I2 = 73 %   
 0 0,02 0,04 0,06 0,08 0,12 0,16 0,2 0,240,1 0,14 0,18 0,22
Prevalencea
▶ Fig. 4a Follow-up and surgery. Overall surgery rate by technique.
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Mortality related to endoscopic procedures was similar
(0.08% in Hassan C. et al. vs. 0.10% in our data) [7].
In this meta-analysis, we included mainly observational co-
hort studies and case-control studies, most of them either sin-
gle-center or retrospective. However, to mitigate the risk of
bias, we used the Newcastle-Ottawa Scale for assessing the
quality of nonrandomized studies.
Limitations
Our search did not retrieve any results on minimally invasive
transanal surgery (transanal endoscopic microsurgery), mostly
because in the studies involving these techniques a morpholo-
gic classification was not applied. It would be advisable to apply
this classification in future studies evaluating these techniques.
One of the major limitations of our work is the heteroge-
neous classification of lesions applied in the different papers.
Many studies on the endoscopic treatment of large (> 10mm)
Paris 0-IIa lesions (as well as 0-IIa + c or 0-IIa + Is) were excluded
because the denomination LST was not present. Most, if not all
these lesions probably correspond to LST. Several studies that
included LST along with other polypoid and non-polypoid le-
sions that didn’t make a subanalysis of LST subgroup were also
excluded. The other major limitation refers to the fact that
most of the studies are either single-center or retrospective.
Data are scarce to compare the outcomes for the different
LST subtypes (LST-GH, LST-GM, LST-NGF and LST-NGPD). For
many non-Japanese studies, chromoendoscopy is not routinely
applied, hence this may affect the accuracy of the morphologi-
cal diagnosis of LST (especially LST-NG-PD) and evaluation of
residual neoplasm in resection margin. The histological charac-
teristics were usually not analyzed and they can play a major
role in the outcomes, as more advanced histological lesions
are related with lower curative resection.
 Study or subgroup Surgery due to recurrence by technique Prev (95 % CI) % Weight
 EMR
 Conio M, 2010  0,000 (0,000, 0,013) 6,1
 Fasoulas K, 2012  0,000 (0,000, 0,035) 2,2
 Urban O, 2008  0,000 (0,000, 0,013) 5,9
 Uraoka T, 2005  0,009 (0,000, 0,027) 10,0
 Tanaka, 2001  0,000 (0,000, 0,021) 3,7
 Tamura S, 2004  0,000 (0,000, 0,026) 3,0
 Huang Y, 2009  0,000 (0,000, 0,017) 4,6
 Hurlstone DP, 2004  0,034 (0,001, 0,101) 2,6
 Binmoller KF, 2015  0,000 (0,000, 0,032) 2,4
 Terasaki (EMR), 2011  0,000 (0,000, 0,010) 7,9
 Hurlstone DP (EMR), 
 2006  0,059 (0,000, 0,236) 0,8
 EMR subgroup  0,005 (0,001, 0,010) 49,3
 Q = 10,58, P = 0,39,
 I2 = 6 %
 ESD
 Niimi K, 2010  0,004 (0,000, 0,017) 11,0
 Nishiyama H, 2010  0,000 (0,000, 0,008) 9,2
 Makino T, 2015  0,000 (0,000, 0,030) 2,6
 Xu MD, 2013  0,000 (0,000, 0,013) 6,2
 Cong ZJ, 2015  0,014 (0,000, 0,042) 6,4
 Zhou PH, 2009  0,000 (0,000, 0,023) 3,3
 Tang XW, 2016  0,000 (0,000, 0,047) 1,6
 Berr F, 2014  0,000 (0,000, 0,052) 1,5
 Probst A, 2012  0,000 (0,000, 0,025) 3,1
 Repici A, 2013  0,000 (0,000, 0,043) 1,8
 Terasaki (ESD), 2011  0,000 (0,000, 0,019) 4,0
 ESD subgroup  0,004 (0,001, 0,009) 50,7
 Q = 3,88, P = 0,95,
  I2 = 0 %      
 Overall  0,005 (0,002, 0,008) 100,0
 Q = 14,51, P = 0,85
 I2 = 0 %   
 0 0,02 0,04 0,06 0,08 0,12 0,16 0,2 0,240,1 0,14 0,18 0,22
Prevalenceb
▶ Fig. 4b Follow-up and surgery. Rate of surgery due to recurrence by technique.
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The duration from endoscopic treatment to surveillance ex-
amination was heterogeneous between the studies and may
have affected the rate of early recurrence.
Conclusion
A wide range of definitions was applied to describe LST, not al-
ways concordant. Therefore, it is of paramount importance to
establish an unambiguous and consensus definition for these
lesions.
Definitions are nearly unanimous in describing LST as flat or
non-polypoid lesions that extend laterally (or horizontally, or
superficially) and circumferentially, rather than vertically along
the colonic wall [20, 30–38].
Although some studies consider a minimum of 20mm of di-
ameter to fit in this classification [39, 40]. Most of the authors
include lesions beyond 10mm in this group [4, 20, 30, 32, 34–
38, 41–44]. Another contention appears when establishing
the maximum allowed vertical growth. Most commonly lateral-
ly spreading lesions within the fully inflated colon are described
as lesions with height of less than half the diameter [45]. Bae JH
et al. [15], defined LST as lesions with less than 2.5mm in
height.
Some authors make no distinction between sessile lesions
and LST [46], while many other authors, despite making this
distinction, analyze them in the same group of large sessile
and laterally spreading lesions [47, 48]. The difference between
large sessile and laterally spreading tumors can actually be dif-
ficult and subjective. The Paris endoscopic classification of su-
perficial neoplastic lesions of 2002 states that slightly elevated
lesions are easily misclassified as sessile (polypoid subtype) at
endoscopy. This distinction is more reliable on pathologic ex-
amination of an operative specimen, in which it is possible to
compare the height of the lesion with the full thickness of the
normal mucosa, although this also has limitations due to speci-
men shrinkage with fixation.
 Study or subgroup Surgery due to incomplete/non-curative resection by technique Prev (95 % CI) % Weight
 EMR
 Moss A, 2015  0,046 (0,032, 0,062) 10,0
 Conio M, 2010  0,051 (0,020, 0,096) 5,7
 Fasoulas K, 2012  0,082 (0,018, 0,178) 2,9
 Urban O, 2008  0,045 (0,015, 0,089) 5,6
 Tanaka, 2001  0,037 (0,005, 0,092) 4,2
 Tamura S, 2004  0,060 (0,013, 0,132) 3,7
 Su MY, 2008  0,080 (0,046, 0,121) 6,9
 Huang Y, 2009  0,039 (0,008, 0,087) 4,9
 Hurlstone DP, 2004  0,000 (0,000, 0,029) 3,3
 Binmoller KF, 2015  0,000 (0,000, 0,032) 3,1
 Terasaki (EMR), 2011  0,011 (0,000, 0,034) 6,5
 EMR subgroup  0,041 (0,026, 0,058) 56,8
 Q = 23,40, P = 0,01,
 I2 = 57 %
 ESD
 Nishiyama H, 2010  0,020 (0,004, 0,044) 6,9
 Jung DH, 2015  0,067 (0,033, 0,112) 6,2
 Xu MD, 2013  0,066 (0,029, 0,114) 5,7
 Cong ZJ, 2015  0,051 (0,023, 0,089) 6,5
 Zhou PH, 2009  0,014 (0,000, 0,057) 3,9
 Tang XW, 2016  0,028 (0,000, 0,116) 2,3
 Hulagu S, 2013  0,023 (0,000, 0,095) 2,7
 Hurlstone DP, 2007  0,000 (0,000, 0,061) 1,9
 Repici A, 2013  0,050 (0,001, 0,145) 2,5
 Terasaki (ESD), 2011  0,077 (0,030, 0,142) 4,5
 ESD subgroup  0,046 (0,030, 0,063) 43,2
 Q = 12,87, P = 0,17,
  I2 = 30 %      
 Overall  0,043 (0,033, 0,055) 100,0
 Q = 36,38, P = 0,01
 I2 = 45 %   
 0 0,02 0,04 0,06 0,08 0,12 0,160,1 0,14 0,18
Prevalencec
▶ Fig. 4c Follow-up and surgery. Rate of surgery due to incomplete resection by technique.
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When applying the Paris classification into the LST sub-clas-
sification, most authors include IIa, IIa + Is and IIa + IIc lesions in
this group [5, 24, 49]. Some studies also classify these lesions as
IIb [18, 24] and IIa + IIb [19]. Berr F et al. classified LST-GH as IIa,
LST-GM as IIa + Is, LST-NGF as IIa or IIb and LST-NGPD as IIa + c
[24]. However, some authors have considered LST-NG as IIa
and LST-G as IIa + Is lesions [49, 50].
Alternatively, some studies differentiate an LST group from a
Paris II group (including IIa lesions), with both groups having
large >10mm lesions [22, 51, 52].
In the Paris consensus of 2002 “lateral spreading type” le-
sions were included in type 0-IIa [3].
The authors suggest the following criteria to classify a lesion
as LST:
1. Flat or non-polypoid lesions that extend laterally and cir-
cumferentially rather than vertically along the colonic wall,
with a minimum diameter of 10mm.
2. Laterally spreading lesions shall be slightly elevated or at
least have a real flat component (0-IIa). Pure sessile lesions
(Paris 0-Is) shall not be classified as LST. To differentiate LST
from sessile lesions the height of these lesions must be less
than half of its diameter.
3. LST shall be classified into LST-G, which includes LST-GH
(which corresponds to Paris 0-IIa lesions) and LST-GM (Paris
0-IIa + Is lesions) and LST-NG, which includes LST-NGF (Paris
0-IIa) and LST-NGPD (Paris 0-IIa + c).
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